News: Press Releases 2010

Get the latest news on Somaxon. Click any link to retrieve the press release in PDF format. (Adobe Acrobat Reader is required). If you don’t have Adobe Acrobat, download it for free from Adobe.

January 21, 2010, SOMAXON PROVIDES UPDATE ON NEW DRUG APPLICATION FOR SILENOR® FOR THE TREATMENT OF INSOMNIA
Resubmission has been filed, with 2 month review cycle
SAN DIEGO, CA – Somaxon Pharmaceuticals, Inc. (Nasdaq: SOMX), a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area, today provided an update on the status of its New Drug Application (NDA) for Silenor® (doxepin) for the treatment of insomnia. (.pdf)

 

Join Our Mailing List

Please join our mailing list if you wish to receive news regarding Somaxon and its products.

Archived Press Releases

2009
2008
2007
2006
2005
2004